首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >An evolutionarily conserved allosteric site modulates beta-lactamase activity
【24h】

An evolutionarily conserved allosteric site modulates beta-lactamase activity

机译:进化保守的变构位点调节β-内酰胺酶活性

获取原文
           

摘要

Abstract Declining efficiency of antibiotic-inhibitor combinatorial therapies in treating beta-lactamase mediated resistance necessitates novel inhibitor development. Allosteric inhibition offers an alternative to conventional drugs that target the conserved active site. Here, we show that the evolutionarily conserved PWP triad located at the N-terminus of the H10 helix directly interacts with the allosteric site in TEM-1 beta-lactamase and regulates its activity. While point mutations in the PWP triad preserve the overall secondary structures around the allosteric site, they result in a more open and dynamic global structure with decreased chemical stability and increased aggregation propensity. These mutant enzymes with a less compact hydrophobic core around the allosteric site displayed significant activity loss. Detailed sequence and structure conservation analyses revealed that the PWP triad is an evolutionarily conserved motif unique to class A beta-lactamases aligning its allosteric site and hence is an effective potential target for enzyme regulation and selective drug design.
机译:摘要抗生素抑制剂组合疗法治疗β-内酰胺酶介导的耐药性的效率下降,需要开发新的抑制剂。变构抑制作用是靶向保守活性位点的常规药物的替代方法。在这里,我们显示位于H10螺旋N末端的进化保守PWP三联体直接与TEM-1β-内酰胺酶的变构位点相互作用,并调节其活性。虽然PWP三合会中的点突变保留了变构位点周围的整体二级结构,但它们导致了更开放和动态的整体结构,化学稳定性降低,聚集倾向增加。这些在变构位点周围具有较不紧密的疏水核心的突变酶显示出明显的活性损失。详细的序列和结构保守性分析表明,PWP三联体是与A类β-内酰胺酶相对应的变构位点所特有的进化保守基序,因此是酶调节和选择性药物设计的有效潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号